Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Surg Res. 2014 Mar 27;190(1):177–184. doi: 10.1016/j.jss.2014.03.069

Figure 3. SLFN12 overexpression changes proliferation of LNCaP cells.

Figure 3

A. Treatment of 50–60% confluent LNCaP with Ad-GFP-SLFN12 for 72 h reduced proliferation compared to Ad-GFP treated control cells. B. Full length Caspase 3 in Ad-GFP and Ad-GFP-SLFN12 treated LNCaP cells. Error bars indicate standard errors. * - p<0.05.